Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05601063 · ClinicalTrials.gov registry record
Ascertaining Diagnosis Classification With Elicited Speech
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 255
- Enrollment target
NCT05601063: Completed study, sponsored by Northwell Health.
NCT05601063 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 255 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05601063 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
Cross-sectional observational study of the relationship between speech patterns and psychiatric symptoms and disorders.
Primary Outcome
Acoustic and linguistic measures of speech computed based on performance on the Winterlight Speech Assessment
Interventions
- BEHAVIORAL Winterlight Speech Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2022-09-01 |
What the finished NCT05601063 record still lists
NCT05601063 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Winterlight Speech Assessment is the first listed.
NCT05601063 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05601063 about?
NCT05601063 is a clinical study titled "Ascertaining Diagnosis Classification With Elicited Speech". Cross-sectional observational study of the relationship between speech patterns and psychiatric symptoms and disorders.
What is the current status of trial NCT05601063?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2020-10-01. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT05601063?
The interventions under investigation include: Winterlight Speech Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05601063?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI